New blood tests are helping doctors diagnose whether Alzheimer’s or something else is causing a patient’s memory problems ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

An ultrasound-based blood assay amplifies tiny amyloid seeds linked to Alzheimer’s and MCI before measuring their activity.